P Weidinger, P M Johnson, S C Werner. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh： See more » AdultAgedAntithyroid Agents/therapeutic useDose-Response Relationship, RadiationDrug Therapy, CombinationEye ManifestationsFemaleFollow-Up StudiesGraves Disease/bloodGraves Disease/drug therapyGraves Disease/radiotherapyHumansHyperthyroidism/etiologyHypothyroidism/etiologyIodine Radioisotopes/adverse effectsIodine Radioisotopes/therapeutic useMaleMiddle AgedPropranolol/therapeutic useRadiotherapy/adverse effectsRadiotherapy DosageThyroglobulin/bloodThyrotropin/bloodTime FactorsTriiodothyronine/blood
Substances： See more » Antithyroid AgentsIodine RadioisotopesTriiodothyronineThyrotropinThyroglobulinPropranolol
Year: 1974 PMID： 4136737 DOI： 10.1016/s0140-6736(74)91636-5
Source DB: PubMed Journal: Lancet ISSN： 0140-6736 Impact factor: 79.321